Applied Materials is the broadest semiconductor equipment platform with #1 positions in deposition, CMP, and epi/implant. Q2 FY2026 (reported May 14) decisively beat: revenue $7.91B vs $7.65B guidance (+3.4%), non-GAAP EPS $2.86 vs $2.66 consensus, non-GAAP gross margin 50.0%. Q3 FY2026 guidance of $8.95B (+/- $500M) implies +23% YoY growth and crushes the $8.09B consensus, prompting management to raise CY2026 chip equipment growth from 20% to over 30%, with advanced packaging projected to grow over 50% in CY2026. SEMI's CY2027 total semi equipment forecast of $156B and CY2026 of $139B (WFE-only segment $135.2B in 2027, +9.0% 2026 / +7.3% 2027; DRAM equipment +15.1% 2026) remain intact. The decisive recent catalyst: on June 1, 2026 Jensen Huang announced at Computex/GTC Taipei that Nvidia's Vera Rubin platform entered FULL PRODUCTION with Samsung, SK Hynix, and Micron named as HBM4 suppliers — a direct, DRAM/HBM-intensive demand pull for AMAT's deposition/etch/CMP tooling that drove AMAT +6.9% to a $490.05 close on June 2 and a further leg to $500.77 (new ATH) on June 3. The Castellano share-loss narrative is discredited: Morgan Stanley has reverted to Overweight with a $502 PT (its prior Equal-Weight downgrade rested on a NAND-mix-favors-LRCX / DRAM-fast-2026-slow-2027 relative call, not segment share loss), and the post-earnings PT cluster now spans Citi $520, Mizuho $540, Deutsche Bank $550, and Cantor Fitzgerald $575, with ~40-analyst consensus near $511 (range $358-$575). The integrated AMAT-Besi Kinex hybrid bonding platform (AMAT is Besi's largest shareholder at 9%, 5-year co-development), the May 3, 2026 NEXX acquisition agreement (panel-level advanced-packaging deposition from ASMPT), and the May 20, 2026 Broadcom EPIC partnership give AMAT a structural advanced-packaging position competitors cannot easily replicate. The principal remaining risk is LRCX's ALD-Moly leadership at sub-2nm GAA (partially mitigated by AMAT's competing Spectral ALD-Moly) plus the NAND-mix relative disadvantage MS flagged. At $647.97 (June 26, 2026 close; ~50x FY2026E non-GAAP EPS ~$12.85, ~34x FY2027E base EPS $19.00), the stock has now run UP TO its raised bull target ($651) after a further +5% leg past the 6/18 $617.11 anchor — the raised base ($570) sits ~12% below spot and the probability-weighted return is -12.1% (PWE $569). The fundamental story remains intact and strengthening, but the price has run past the disciplined EPS x P/E target band — risk-reward is skewed to downside. Conviction: Hold.